ARTICLE | Clinical News
Oral phentolamine: Began Phase II trials in Germany in 160 patients; an IND is expected to be filed in the U.S. this year
January 30, 1995 8:00 AM UTC
Zonagen Inc. (ZONA), The Woodlands, Texas Product: Oral phentolamine Indication: Male impotency Status: Began Phase II trials in Germany in 160 patients; an IND is expected to be filed in the U.S. thi...